STOCK OPTIONS AND WARRANTS (Details 2) |
9 Months Ended |
---|---|
Sep. 30, 2018
shares
| |
Stock Options [Member] | |
Weighted average remaining life in years | 8 years 2 months 12 days |
Stock Options [Member] | |
Number of options | 79,385,000 |
Exercisable number of options | 55,760,000 |
0.01-0.025 [Member] | |
Number of options | 33,035,000 |
Weighted average remaining life in years | 8 years |
Exercisable number of options | 33,035,000 |
0.0251-0.05 [Member] | |
Number of options | 3,500,000 |
Weighted average remaining life in years | 2 years 1 month 6 days |
Exercisable number of options | 3,500,000 |
0.051-0.14 [Member] | |
Number of options | 42,850,000 |
Weighted average remaining life in years | 8 years 10 months 25 days |
Exercisable number of options | 19,225,000 |
X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|